Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group. · 2003
Read Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. by Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group. (2003) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2394471.txt.
Description
Koukourakis and colleagues, with the Tumour and Angiogenesis Research Group, studied a sugar-burning enzyme in lung cancer in 2003. The enzyme, LDH-5, converts pyruvate to lactate, the hallmark step of oxygen-free energy production in cells. Tumors low on oxygen switch it on through the HIF system, the cell's oxygen alarm.
They built a staining test for LDH-5 and applied it to non-small-cell lung cancers, the common form. High LDH-5 tracked closely with the alarm proteins HIF1 alpha and HIF2 alpha in the same tumors. Patients whose tumors carried high LDH-5 had a poor prognosis. Tumors high in both LDH-5 and a HIF protein behaved especially aggressively. Blood LDH levels, though related, did not reliably mirror the tumor's own level. The authors said the stain gives easy prognostic information from stored tumor samples.
Catalog record
| CREATOR | Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group. |
|---|---|
| YEAR | 2003 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |